Back to Journals » Journal of Inflammation Research » Volume 3 » default
Journal of Inflammation Research
ISSN: 1178-7031
- View all (2170)
- Volume 17, 2024 (329)
- Volume 16, 2023 (460)
- Volume 15, 2022 (493)
- Volume 14, 2021 (541)
- Volume 13, 2020 (112)
- Volume 12, 2019 (35)
- Volume 11, 2018 (47)
- Volume 10, 2017 (20)
- Volume 9, 2016 (24)
- Volume 8, 2015 (21)
- Volume 7, 2014 (17)
- Volume 6, 2013 (14)
- Volume 5, 2012 (17)
- Volume 4, 2011 (13)
- Volume 3, 2010 (15)
- Volume 2, 2009 (6)
- Volume 1, 2008 (6)
Archive: Volume 3, 2010
Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation
Undurti N Das
Journal of Inflammation Research 2010, 3:143-170
Published Date: 2 December 2010
Current and emerging strategies for the treatment of acute pericarditis: a systematic review
Samar Sheth, Dee Dee Wang, Christos Kasapis
Journal of Inflammation Research 2010, 3:135-142
Published Date: 25 November 2010
Deletion of PPAR-γ in immune cells enhances susceptibility to antiglomerular basement membrane disease
Cristen Chafin, Sarah Muse, Raquel Hontecillas, et al
Journal of Inflammation Research 2010, 3:127-134
Published Date: 28 October 2010
The effect of smoking on the symptoms and progression of multiple sclerosis: a review
Afsaneh Shirani, Helen Tremlett
Journal of Inflammation Research 2010, 3:115-126
Published Date: 1 September 2010
Correlation of measurable serum markers of inflammation with lung levels following bilateral femur fracture in a rat model
Benjamin W Sears, Dustin Volkmer, Sherri Yong, et al
Journal of Inflammation Research 2010, 3:105-114
Published Date: 26 August 2010
Prostate cancer cells undergoing ER stress in vitro and in vivo activate transcription of pro-inflammatory cytokines
Navin R Mahadevan, Antonio Fernandez, Jeffrey J Rodvold, et al
Journal of Inflammation Research 2010, 3:99-103
Published Date: 20 August 2010
Inflammatory cytokines and atrial fibrillation: current and prospective views
Hadi AR Hadi, Alawi A Alsheikh-Ali, Wael AL Mahmeed, et al.
Journal of Inflammation Research 2010, 3:75-97
Published Date: 30 August 2010
Potential of anti-inflammatory treatment for cystic fibrosis lung disease
Jennifer L Taylor-Cousar, Kelsey A Von Kessel, Robert Young, et al
Journal of Inflammation Research 2010, 3:61-74
Published Date: 10 August 2010
Emerging therapies for treatment of multiple sclerosis
John R Corboy, Augusto A Miravalle
Journal of Inflammation Research 2010, 3:53-59
Published Date: 23 July 2010
Immune response profiles after caterpillar exposure: a case report
Tamar A Smith-Norowitz, Kevin B Norowitz, Stephan Kohlhoff, et al
Journal of Inflammation Research 2010, 3:45-51
Published Date: 16 July 2010
Current perspectives on the role of IL-17 in autoimmune disease
Hisakata Yamada
Journal of Inflammation Research 2010, 3:33-44
Published Date: 18 June 2010
Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
Slobodan M Jankovic
Journal of Inflammation Research 2010, 3:25-31
Published Date: 16 March 2010
Existence of seven human IL-1R1 promoters
Qiming Li, Hao Zhang, Qun Chen, et al
Journal of Inflammation Research 2010, 3:17-24
Published Date: 25 February 2010
Topical alpha-selective p38 MAP kinase inhibition reduces acute skin inflammation in guinea pig
Satyanarayana Medicherla, Jing Ying Ma, Mamtha Reddy, et al
Journal of Inflammation Research 2010, 3:9-16
Published Date: 18 February 2010
Rilonacept in the management of cryopyrin-associated periodic syndromes (CAPS)
Justin Gillespie, Rebeccah Mathews, Michael F McDermott
Journal of Inflammation Research 2010, 3:1-8
Published Date: 19 January 2010